Michel Vounatsos

	Use attributes for filter !
Date of Reg.	2022-01-11 20:19:55
Date of Upd.	2022-01-11 20:20:13
ID	3235722

Send edit request

About Michel Vounatsos

Michel Vounatsos is Chief Executive Officer at Biogen and has served as a director since January 2017. As CEO, his time has been spent strategically bolstering Biogen as a worldwide pioneer in neuroscience and adjacent therapeutic areas, positioning the company for long-term growth through a multi-franchise portfolio.

Alzheimer's-slowing drug labelled historic

Oct 1,2022 10:00 am

... Truly encouraging Biogen chief executive Michel Vounatsos said: " Today s announcement gives patients and their families hope that lecanemab, if approved, can potentially slow the progression of Alzheimer s disease and provide a clinically meaningful impact on cognition and function...